Xiaoyan Wu

TL;DR: This case series study evaluates the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).

TL;DR: The identified independent risk factors suggest that fatality due to COVID-19 was associated with multiple organ dysfunction, and can help identify the high-risk patients of CO VID-19 with poor prognosis in order to offer early warning and intervention, and also help funnel the flow of patient with COVID -19.

TL;DR: The use of statins in COVID-19 patients was associated with better clinical outcomes and is recommended to be continued in patients with CO VID-19.

TL;DR: Wang et al. as discussed by the authors further explored the sustained impact of COVID-19 during follow-up, focusing on the cardiac involvement in the recovered patients and found that patients with cardiac injury were more prone to develop cardiac fibrosis during their recovery.

TL;DR: The altered degree centrality may serve as early biomarkers for CI in ESRD patients and positive correlations were found between DC values on the right superior frontal gyrus and LDL and BDST, and between MoCA and the DCvalues on the left insula and the left postcentral gyrus.